Vanda Pharmaceuticals (VNDA) Capital Expenditures (2011 - 2026)
Vanda Pharmaceuticals recorded quarterly Capital Expenditures of $221000.0 in Q1 2026, up 116.67% quarter-over-quarter from $102000.0 in Q4 2025, and down 49.31% year-over-year from $436000.0 in Q1 2025.
Vanda Pharmaceuticals' Capital Expenditures history runs 16 years deep, the most recent figure standing at $221000.0 for Q1 2026.
- In Q1 2026, Capital Expenditures fell 49.31% year-over-year to $221000.0; the TTM figure through Mar 2026 stood at $783000.0 (down 14.8% YoY), while the FY2025 annual figure was $998000.0, up 103.67% from the prior year.
- Capital Expenditures came in at $221000.0 for Q1 2026 at Vanda Pharmaceuticals, up from $102000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $436000.0 in Q1 2025 to a low of $7000.0 in Q1 2024.
- A 5-year average of $163000.0 and a median of $161000.0 in 2024 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures sank 86.27% in 2024 and jumped 6128.57% in 2025, its largest moves.
- Vanda Pharmaceuticals' Capital Expenditures stood at $263000.0 in 2022, then slipped by 3.8% to $253000.0 in 2023, then decreased by 15.42% to $214000.0 in 2024, then tumbled by 52.34% to $102000.0 in 2025, then surged by 116.67% to $221000.0 in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $221000.0, $102000.0, and $161000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 133.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 230.60 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21.83 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | 221,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 221,000.00 |
| Mar 31, 2026 | 221,000.00 |
| Dec 31, 2025 | 102,000.00 |
| Dec 31, 2025 | 102,000.00 |
| Sep 30, 2025 | 161,000.00 |
| Sep 30, 2025 | 161,000.00 |
| Jun 30, 2025 | 299,000.00 |
| Jun 30, 2025 | 299,000.00 |
| Mar 31, 2025 | 436,000.00 |
| Mar 31, 2025 | 436,000.00 |
| Dec 31, 2024 | 214,000.00 |
| Dec 31, 2024 | 214,000.00 |
| Sep 30, 2024 | 161,000.00 |
| Sep 30, 2024 | 161,000.00 |
| Jun 30, 2024 | 108,000.00 |
| Jun 30, 2024 | 108,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Mar 31, 2024 | 7,000.00 |
| Dec 31, 2023 | 253,000.00 |
| Dec 31, 2023 | 253,000.00 |
| Sep 30, 2023 | 24,000.00 |
| Sep 30, 2023 | 24,000.00 |
| Jun 30, 2023 | 55,000.00 |
| Jun 30, 2023 | 55,000.00 |
| Mar 31, 2023 | 51,000.00 |
| Mar 31, 2023 | 51,000.00 |
| Dec 31, 2022 | 263,000.00 |
| Dec 31, 2022 | 263,000.00 |
| Sep 30, 2022 | 148,000.00 |
| Sep 30, 2022 | 148,000.00 |
| Jun 30, 2022 | 193,000.00 |
| Jun 30, 2022 | 193,000.00 |
| Mar 31, 2022 | 75,000.00 |
| Mar 31, 2022 | 75,000.00 |
| Dec 31, 2021 | 134,000.00 |
| Dec 31, 2021 | 134,000.00 |
| Sep 30, 2021 | -10,000.00 |
| Sep 30, 2021 | -10,000.00 |
| Jun 30, 2021 | 298,000.00 |
| Jun 30, 2021 | 298,000.00 |
| Mar 31, 2021 | 130,000.00 |
| Mar 31, 2021 | 130,000.00 |
| Dec 31, 2020 | 966,000.00 |
| Dec 31, 2020 | 966,000.00 |
| Sep 30, 2020 | 246,000.00 |
| Sep 30, 2020 | 246,000.00 |
| Jun 30, 2020 | 210,000.00 |
| Jun 30, 2020 | 210,000.00 |
| Mar 31, 2020 | 373,000.00 |
| Mar 31, 2020 | 373,000.00 |
| Dec 31, 2019 | 68,000.00 |
| Dec 31, 2019 | 68,000.00 |
| Sep 30, 2019 | 294,000.00 |
| Sep 30, 2019 | 294,000.00 |
| Jun 30, 2019 | 264,000.00 |
| Jun 30, 2019 | 264,000.00 |
| Mar 31, 2019 | 393,000.00 |
| Mar 31, 2019 | 393,000.00 |
| Dec 31, 2018 | 22,000.00 |
| Dec 31, 2018 | 22,000.00 |
| Sep 30, 2018 | 136,000.00 |
| Sep 30, 2018 | 136,000.00 |
| Jun 30, 2018 | 75,000.00 |
| Jun 30, 2018 | 75,000.00 |
| Mar 31, 2018 | 135,000.00 |
| Mar 31, 2018 | 135,000.00 |
| Dec 31, 2017 | 191,000.00 |
| Dec 31, 2017 | 191,000.00 |
| Sep 30, 2017 | 371,000.00 |
| Sep 30, 2017 | 371,000.00 |
| Jun 30, 2017 | 624,000.00 |
| Jun 30, 2017 | 624,000.00 |
| Mar 31, 2017 | 478,000.00 |
| Mar 31, 2017 | 478,000.00 |
| Dec 31, 2016 | 697,000.00 |
| Dec 31, 2016 | 697,000.00 |
| Sep 30, 2016 | 599,000.00 |
| Sep 30, 2016 | 599,000.00 |
| Dec 31, 2015 | 714,000.00 |
| Dec 31, 2015 | 714,000.00 |
| Sep 30, 2015 | 874,000.00 |
| Sep 30, 2015 | 874,000.00 |
| Jun 30, 2015 | 156,000.00 |
| Jun 30, 2015 | 156,000.00 |
| Mar 31, 2015 | 783,000.00 |
| Mar 31, 2015 | 783,000.00 |
| Dec 31, 2014 | 338,000.00 |
| Dec 31, 2014 | 338,000.00 |
| Sep 30, 2014 | 53,000.00 |
| Sep 30, 2014 | 53,000.00 |
| Jun 30, 2014 | 243,000.00 |
| Jun 30, 2014 | 243,000.00 |
| Mar 31, 2014 | 135,000.00 |
| Mar 31, 2014 | 135,000.00 |
| Dec 31, 2013 | 97,000.00 |
| Dec 31, 2013 | 97,000.00 |
| Sep 30, 2013 | 7,000.00 |
| Sep 30, 2013 | 7,000.00 |
| Jun 30, 2013 | 49,000.00 |
| Jun 30, 2013 | 49,000.00 |
| Mar 31, 2013 | 23,000.00 |
| Mar 31, 2013 | 23,000.00 |
| Dec 31, 2012 | 7,000.00 |
| Dec 31, 2012 | 7,000.00 |
| Sep 30, 2012 | 17,000.00 |
| Sep 30, 2012 | 17,000.00 |
| Jun 30, 2012 | 148,000.00 |
| Jun 30, 2012 | 148,000.00 |
| Mar 31, 2012 | 1.85 Mn |
| Mar 31, 2012 | 1.85 Mn |
| Dec 31, 2011 | 77,000.00 |
| Dec 31, 2011 | 77,000.00 |
| Sep 30, 2011 | 34,000.00 |
| Sep 30, 2011 | 34,000.00 |